Artia Global Partners as of Dec. 31, 2023
Portfolio Holdings for Artia Global Partners
Artia Global Partners holds 31 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Novo-nordisk A S Adr (NVO) | 21.7 | $75M | 722k | 103.45 | |
| Eli Lilly & Co. (LLY) | 15.7 | $54M | 93k | 582.92 | |
| Merck & Co (MRK) | 10.4 | $36M | 329k | 109.02 | |
| Cytokinetics Call Call Option | 9.8 | $34M | 405k | 83.49 | |
| Cytokinetics Put Put Option | 9.7 | $33M | 401k | 83.49 | |
| Eli Lilly & Co Put Put Option | 6.8 | $23M | 40k | 582.92 | |
| Abbvie (ABBV) | 4.1 | $14M | 91k | 154.97 | |
| Argenx Se Sponsored Adr (ARGX) | 3.8 | $13M | 34k | 380.43 | |
| Astrazeneca Sponsored Adr (AZN) | 3.7 | $13M | 191k | 67.35 | |
| Viking Therapeutics (VKTX) | 2.1 | $7.1M | 384k | 18.61 | |
| Axsome Therapeutics (AXSM) | 2.0 | $7.0M | 88k | 79.59 | |
| Neurocrine Biosciences (NBIX) | 1.7 | $5.9M | 45k | 131.76 | |
| Intra Cellular Therapies (ITCI) | 0.9 | $3.0M | 42k | 71.62 | |
| BioMarin Pharmaceutical (BMRN) | 0.8 | $2.8M | 29k | 96.42 | |
| Cytokinetics Com New (CYTK) | 0.8 | $2.7M | 32k | 83.49 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.8 | $2.6M | 131k | 19.88 | |
| Protagonist Therapeutics (PTGX) | 0.7 | $2.6M | 112k | 22.93 | |
| Vaxcyte (PCVX) | 0.7 | $2.4M | 39k | 62.80 | |
| Insmed Com Par $.01 (INSM) | 0.7 | $2.3M | 75k | 30.99 | |
| Ocular Therapeutix (OCUL) | 0.6 | $2.0M | 440k | 4.46 | |
| Pliant Therapeutics (PLRX) | 0.5 | $1.8M | 100k | 18.11 | |
| Charles River Laboratories (CRL) | 0.5 | $1.6M | 6.9k | 236.40 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.3 | $1.2M | 50k | 23.11 | |
| Waters Corporation (WAT) | 0.3 | $937k | 2.8k | 329.23 | |
| Immunovant (IMVT) | 0.3 | $902k | 21k | 42.13 | |
| Rapt Therapeutics (RAPT) | 0.1 | $488k | 20k | 24.85 | |
| Structure Therapeutics Put Put Option | 0.1 | $408k | 10k | 40.76 | |
| Biomea Fusion (BMEA) | 0.1 | $370k | 26k | 14.52 | |
| Apogee Therapeutics (APGE) | 0.1 | $290k | 10k | 27.94 | |
| Gritstone Oncology Ord (GRTS) | 0.1 | $194k | 95k | 2.04 | |
| Tyra Biosciences (TYRA) | 0.0 | $142k | 10k | 13.85 |
